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In 2018, over 18 million new cancer cases emerged [1]. Progresses accomplished in 
cancer treatment, namely in the development of effective ant-cancer drugs (e.g., cytostatics) 
allow cancer patients to live better and longer [2]. Nevertheless, cytostatics, as with other 
drugs, are excreted through urine, reaching wastewater treatment plants (WWTPs), and 
subsequently contaminating the aquatic environment [3, 4]. 
A promising technological tool to remove cytostatic drugs from aqueous matrices is 
represented by the use of supported ionic liquids (SILs). This work is aimed at synthesizing 
and characterizing several SILs based on quaternary ammonium structures using silica as 
the support material. The determination of adsorption kinetics and isotherms was then 
carried out to infer on SILs adsorption capacity for cyclophosphamide (model cytostatic 
drug). SILs capacity to remove cyclophosphamide from aqueous samples was contingent on 
the cation structure, opening the way to design effective alternative adsorbents for cytostatics 
removal. 
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